Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
International Immunology|August 26, 2020
Type I interferons induce peripheral T regulatory cell differentiation under tolerogenic conditionsSara Vitale, Valentina Russo, Beatrice Dettori, et al.Cancer Research|July 3, 2008
Pyrimethamine induces apoptosis of melanoma cells via a caspase and cathepsin double-edged mechanismAnna Maria Giammarioli, Angela Maselli, Andrea Casagrande, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2013
Cyclophosphamide induces a type I interferon-associated sterile inflammatory response signature in cancer patients' blood cells: implications for cancer chemoimmunotherapyFederica Moschella, Giovanni Fernando Torelli, Mara Valentini, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltrationLaura Bracci, Federica Moschella, Paola Sestili, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 9, 2008
Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require Toll-like receptor triggeringLaura Bracci, Reto Schumacher, Maurizio Provenzano, et al.Journal of Molecular Medicine (Berlin, Germany)|December 29, 2017
Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cellsSimona Anticoli, Eleonora Aricò, Claudia Arenaccio, et al.Cytokine & Growth Factor Reviews|June 22, 2017
Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT)Vincenzo Russo, Alberto Amadori, Marco Bregni, et al.Oncoimmunology|December 8, 2018
Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patientsBelinda Palermo, Ornella Franzese, Cosmo Di Donna, et al.Frontiers in Oncology|June 5, 2023
Blood immune cells as potential biomarkers predicting relapse-free survival of stage III/IV resected melanoma patients treated with peptide-based vaccination and interferon-alphaFederica Moschella, Carla Buccione, Irene Ruspantini, et al.Cancer Research|December 16, 2010
Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosisGiovanna Schiavoni, Antonella Sistigu, Mara Valentini, et al.Pageof 4